| Popis: |
Brożyna Klaudia, Tkaczyk Jędrzej, Baltaziak Katarzyna, Ciechański Krystian, Baltaziak Lucyna, Rejdak Robert. Treatment of age related macular degeneration (AMD) currently and in the past. Journal of Education, Health and Sport. 2018;8(8):850-861. eISNN 2391-8306. DOI http://dx.doi.org/10.5281/zenodo.1403011 http://ojs.ukw.edu.pl/index.php/johs/article/view/5860 https://pbn.nauka.gov.pl/sedno-webapp/works/874544 The journal has had 7 points in Ministry of Science and Higher Education parametric evaluation. Part b item 1223 (26/01/2017). 1223 Journal of Education, Health and Sport eissn 2391-8306 7 © The Authors 2018; This article is published with open access at Licensee Open Journal Systems of Kazimierz Wielki University in Bydgoszcz, Poland Open Access. This article is distributed under the terms of the Creative Commons Attribution Noncommercial License which permits any noncommercial use, distribution, and reproduction in any medium, provided the original author (s) and source are credited. This is an open access article licensed under the terms of the Creative Commons Attribution Non commercial license Share alike. (http://creativecommons.org/licenses/by-nc-sa/4.0/) which permits unrestricted, non commercial use, distribution and reproduction in any medium, provided the work is properly cited. The authors declare that there is no conflict of interests regarding the publication of this paper. Received: 02.06.2018. Revised: 18.06.2018. Accepted: 24.08.2018. Treatment of age related macular degeneration (AMD) currently and in the past Klaudia Brożyna1, Jędrzej Tkaczyk1, Katarzyna Baltaziak2, KrystianCiechański1, Lucyna Baltaziak3, Robert Rejdak3 1Student`s Research Group at the Department of Epidemiology and Clinical Research Methodology, Medical University of Lublin 2Student`s Research Group at the Clinical Department of Ophthalmology, Medical University of Lublin 3Clinical Department of General Ophthalmology, Medical University of Lublin Abstract: Age-related macular degeneration (AMD) is a disease that blurs the sharp, central vision you need for “straight-ahead” activities such as reading, sewing, and driving. AMD affects the macula, the part of the eye that allows you to see fine detail. AMD causes nopain. AMD is an irreparable disorder, which mostly occurs among people after 50. Nowadays the pathogenesis of AMD is still not entirely clarified, however, this disorder has multifactor background, which include interactions between genetic and environmental factors. AMD is divided into two forms: exudative (“wet”) and nonexudative (“dry”). The treatment of age-related macular degeneration depends on the stage of the disease progression. One of the first methods of treatment of exudative AMD was laser photocoagulation with argon laser. Currently, this kind of treatment is used in certain cases of neovascularization in extrafoveal area. Next elderly method of therapy of AMD was a photodynamic therapy (PDT) at year 2000. The treatment consist in intravenous injection of verteporfin and a laser at the same time. At 2002 was in use transpupillary thermotherapy (TTT). Last few years for treatment AMD is used antagonist of vascular endothelial growth factor (VEGF). We distinguish: pegatanib, ranibizumab, bevacizumab and aflibercept. Nowadays all of available methods do not eliminate causes of that disorder and in this connection currently treatment is still symptomatic. Apart from every mentioned method above, nutritional therapy is also essential and it decrease the risk of progression of AMD. The diet should contain products full of vitamin C,E, beta carotene, zinc and cooper. |
